Apotex Health Corp. (TSX:APTX)
Canada flag Canada · Delayed Price · Currency is CAD
39.67
+2.13 (5.67%)
At close: Jul 21, 2026

Apotex Health Company Description

Apotex Health Corp. operates as a pharmaceutical manufacturing company in Canada, the United States, Mexico, and India.

The company develops, manufactures, and distributes a broad portfolio of prescription and generic pharmaceuticals, oncology biosimilar pharmaceuticals, branded specialty pharmaceuticals, and branded consumer health and wellness products.

It operates through three business lines including conventional generic pharmaceuticals; specialty generic pharmaceuticals; and brands & biosimilars.

The company has a a strategic partnership with Halo Pharmaceutical, Inc. The company was formerly known as Artemis Parent, Inc. and changed its name to Apotex Health Corp. in May 2026.

Apotex Health Corp. was founded in 1974 and is headquartered in Toronto, Canada. Apotex Health Corp. operates as a subsidiary of SK Artemis Holdings, II, LLC

Apotex Health Corp.
CountryCanada
Founded1974
IndustryDrug Manufacturers - Specialty & Generic
SectorHealthcare
Employees6,216
CEOJeff Watson

Contact Details

Address:
150 Signet Drive
Toronto, ON M9L 1T9
Canada
Phone(800) 268-4623
Websiteapotex.com

Stock Details

Ticker SymbolAPTX
ExchangeToronto Stock Exchange
Fiscal YearApril - March
Reporting CurrencyCAD
ISIN NumberCA03772D1015
SIC Code2834

Key Executives

NamePosition
Jeff WatsonPresident, Chief Executive Officer and Director
Brian McClellandChief Financial Officer
Ariel AlonChief Operating Officer
Francesco TallaricoChief Legal Officer and Global Head of Government Relations
Barry FishmanChief Corporate Development Officer
Carina Vassilieva C.C.P., G.R.P., M.B.A.Chief Human Resources Officer
Dr. Kiran Krishnan Ph.D.Senior Vice President of Global Regulatory Affairs
Martin ArèsPresident of Canada and Rest of World
Christine BaederPresident of Apotex USA and LATAM
Dr. Pradeep SanghviExecutive Vice President of Global Research and Development